TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Atlas Arteria ( (AU:ALX) ) just unveiled an update.
Atlas Arteria reported a statutory net profit after tax of $73.3 million for the first half of 2025, impacted by a Temporary Supplemental Tax. Despite this, the company saw an 8.1% growth in toll revenue due to toll increases and favorable foreign exchange rates. The company is pursuing growth projects in France and moving forward with litigation and rate applications in North America. The reaffirmation of its 2025 distribution guidance at 40.0 cents per security demonstrates confidence in its financial stability, supported by growing free cash flow.
The most recent analyst rating on (AU:ALX) stock is a Buy with a A$5.70 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a company operating in the infrastructure industry, primarily focusing on toll road management and development. It is involved in various projects across Europe and North America, partnering with companies like Eiffage to enhance road experiences and expand its portfolio.
Average Trading Volume: 2,012,556
Technical Sentiment Signal: Buy
Current Market Cap: A$7.82B
See more insights into ALX stock on TipRanks’ Stock Analysis page.